ACET
Price
$0.69
Change
-$0.03 (-4.17%)
Updated
May 23 closing price
Capitalization
57.37M
74 days until earnings call
ARWR
Price
$15.13
Change
-$0.18 (-1.18%)
Updated
May 23 closing price
Capitalization
2.09B
79 days until earnings call
Interact to see
Advertisement

ACET vs ARWR

Header iconACET vs ARWR Comparison
Open Charts ACET vs ARWRBanner chart's image
Adicet Bio
Price$0.69
Change-$0.03 (-4.17%)
Volume$500.34K
Capitalization57.37M
Arrowhead Pharmaceuticals
Price$15.13
Change-$0.18 (-1.18%)
Volume$1.23M
Capitalization2.09B
ACET vs ARWR Comparison Chart
Loading...
ACET
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ARWR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACET vs. ARWR commentary
May 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACET is a Hold and ARWR is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
May 24, 2025
Stock price -- (ACET: $0.69 vs. ARWR: $15.13)
Brand notoriety: ACET: Not notable vs. ARWR: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACET: 86% vs. ARWR: 66%
Market capitalization -- ACET: $57.37M vs. ARWR: $2.09B
ACET [@Biotechnology] is valued at $57.37M. ARWR’s [@Biotechnology] market capitalization is $2.09B. The market cap for tickers in the [@Biotechnology] industry ranges from $298.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACET’s FA Score shows that 1 FA rating(s) are green whileARWR’s FA Score has 1 green FA rating(s).

  • ACET’s FA Score: 1 green, 4 red.
  • ARWR’s FA Score: 1 green, 4 red.
According to our system of comparison, ACET is a better buy in the long-term than ARWR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACET’s TA Score shows that 7 TA indicator(s) are bullish while ARWR’s TA Score has 5 bullish TA indicator(s).

  • ACET’s TA Score: 7 bullish, 2 bearish.
  • ARWR’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ACET is a better buy in the short-term than ARWR.

Price Growth

ACET (@Biotechnology) experienced а -10.76% price change this week, while ARWR (@Biotechnology) price change was -3.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.22%. For the same industry, the average monthly price growth was +3.23%, and the average quarterly price growth was -2.73%.

Reported Earning Dates

ACET is expected to report earnings on Aug 06, 2025.

ARWR is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+1.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARWR($2.09B) has a higher market cap than ACET($57.4M). ARWR YTD gains are higher at: -19.521 vs. ACET (-27.900). ACET has higher annual earnings (EBITDA): -110.82M vs. ARWR (-580.69M). ARWR has more cash in the bank: 553M vs. ACET (150M). ACET has less debt than ARWR: ACET (16.2M) vs ARWR (525M). ARWR has higher revenues than ACET: ARWR (2.5M) vs ACET (0).
ACETARWRACET / ARWR
Capitalization57.4M2.09B3%
EBITDA-110.82M-580.69M19%
Gain YTD-27.900-19.521143%
P/E RatioN/AN/A-
Revenue02.5M-
Total Cash150M553M27%
Total Debt16.2M525M3%
FUNDAMENTALS RATINGS
ACET vs ARWR: Fundamental Ratings
ACET
ARWR
OUTLOOK RATING
1..100
7818
VALUATION
overvalued / fair valued / undervalued
1..100
34
Fair valued
94
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9499
PRICE GROWTH RATING
1..100
6158
P/E GROWTH RATING
1..100
162
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACET's Valuation (34) in the Medical Distributors industry is somewhat better than the same rating for ARWR (94) in the Biotechnology industry. This means that ACET’s stock grew somewhat faster than ARWR’s over the last 12 months.

ACET's Profit vs Risk Rating (100) in the Medical Distributors industry is in the same range as ARWR (100) in the Biotechnology industry. This means that ACET’s stock grew similarly to ARWR’s over the last 12 months.

ACET's SMR Rating (94) in the Medical Distributors industry is in the same range as ARWR (99) in the Biotechnology industry. This means that ACET’s stock grew similarly to ARWR’s over the last 12 months.

ARWR's Price Growth Rating (58) in the Biotechnology industry is in the same range as ACET (61) in the Medical Distributors industry. This means that ARWR’s stock grew similarly to ACET’s over the last 12 months.

ARWR's P/E Growth Rating (2) in the Biotechnology industry is in the same range as ACET (16) in the Medical Distributors industry. This means that ARWR’s stock grew similarly to ACET’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACETARWR
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
80%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
70%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 13 days ago
82%
Bullish Trend 5 days ago
81%
Declines
ODDS (%)
Bearish Trend 10 days ago
88%
Bearish Trend 18 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
66%
Bearish Trend 2 days ago
79%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
68%
View a ticker or compare two or three
Interact to see
Advertisement
ACET
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ARWR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NSPR2.530.31
+13.71%
InspireMD
AQST2.350.06
+2.62%
Aquestive Therapeutics
SE164.060.80
+0.49%
Sea Limited
RYAN68.65-0.19
-0.28%
Ryan Specialty Holdings
IRON47.37-1.52
-3.11%
Disc Medicine

ACET and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACET has been loosely correlated with RGNX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ACET jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACET
1D Price
Change %
ACET100%
-3.49%
RGNX - ACET
41%
Loosely correlated
+0.73%
OGI - ACET
41%
Loosely correlated
N/A
DVAX - ACET
39%
Loosely correlated
-0.20%
ARWR - ACET
37%
Loosely correlated
-1.18%
SLDB - ACET
37%
Loosely correlated
-2.77%
More

ARWR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARWR has been loosely correlated with NTLA. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if ARWR jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARWR
1D Price
Change %
ARWR100%
-1.18%
NTLA - ARWR
55%
Loosely correlated
-3.17%
RGNX - ARWR
54%
Loosely correlated
+0.73%
DNLI - ARWR
54%
Loosely correlated
-1.76%
BEAM - ARWR
52%
Loosely correlated
-2.26%
YMAB - ARWR
52%
Loosely correlated
+5.37%
More